EvAccess is a strategic market access and outcomes research consulting company founded by Isabelle Chabot PhD in January 2014. We foster access to new medicines in Canada with proven expertise in developing and communicating evidence to health technology assessment (HTA) and health policy audiences. EvAccess’ goal is to help customers identify and strategically meet their HTA and program evaluation needs with an evidence-based focus. EvAccess develops high quality yet simple approaches to support decision-makers in their assessment of HTA evidences. We systematically review available evidence, advise customers on evidence gaps, provide solutions to bridge those gaps and communicate value with maximal transparency. We also design drug utilization management protocols and facilitate their implementation in clinical practice. Our overarching goal is to support optimal patient health outcomes through improved access to medicines and appropriate use of medications.